Thrivent Partner Healthcare Portfolio
Data updated: 2026-05-28
C000062736 — Thrivent Partner Healthcare Portfolio data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $222.55M AUM · 0.92% expense ratio · 1.0% 1-yr return. From SEC regulatory filings.
C000062736 Fund Overview
Thrivent Partner Healthcare Portfolio is a US mutual fund managed by Thrivent Series Fund Inc, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Thrivent Series Fund Inc
- Category: United States Health Care Equity
- Assets under management: $222.55M
- 1-year return: 1.0%
- SEC CIK: 0000790166
- SEC series ID: S000021867
- Share class ID: C000062736
C000062736 Holdings
Top 10 holdings of Thrivent Partner Healthcare Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly And Company | 13.12% |
| Johnson & Johnson | 9.49% |
| Abbvie, Inc. | 6.89% |
| Merck & Co., Inc. | 5.54% |
| Unitedhealth Group, Inc. | 4.99% |
| Stryker Corporation | 3.75% |
| Danaher Corporation | 3.41% |
| Amgen, Inc. | 3.22% |
| Abbott Laboratories | 2.91% |
| Gilead Sciences, Inc. | 2.74% |
C000062736 Portfolio Allocation
Asset-class allocation of Thrivent Partner Healthcare Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.8% |
| Other | 0.7% |
C000062736 Performance
Total returns for C000062736 (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -5.7% |
| 1 year | 1.0% |
| 3 years (annualised) | 4.4% |
| 5 years (annualised) | 3.3% |
C000062736 Risk Information
Risk metrics for C000062736, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.8%
C000062736 Costs and Fees
C000062736 costs about $92 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.92%
- Gross expense ratio: 0.92%
- Portfolio turnover: 17%
- Brokerage commissions: 1.36 bps of average net assets (SEC N-CEN)
C000062736 Cashflows
Over the 12 months to 2026-03, Thrivent Partner Healthcare Portfolio had net outflows of $31.83M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$2.57M |
| 2026-02 | −$1.84M |
| 2026-01 | −$4.28M |
| 2025-12 | −$6.41M |
| 2025-11 | −$3.87M |
| 2025-10 | −$4.65M |
C000062736 Debt Constituents
No individual debt constituents are reported in Thrivent Partner Healthcare Portfolio's latest SEC N-PORT filing.
C000062736 Prospectus and SEC Filings
Official Thrivent Partner Healthcare Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.